It is a major challenge to identify and evaluate the commercial potential of life science inventions. PharmaPlus is experienced in screening universities and other research institutes to identify innovative early stage life science inventions that potentially can be commercialized.
For one of the top 200 universities in Europe (2018 European University Ranking) we identified almost 300 germs with commercial potential upon screening 50 medical departments.
Do you want to learn more about our screening services for your research institutes?
Please contact us for further information.